HZNP
Adage Capital Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,936,633
| Closed | -$340M | – | 968 |
|
|
2023
Q3 | $340M | Sell |
2,936,633
-57,973
| -2% | -$6.71M | 0.77% | 18 |
|
|
2023
Q2 | $308M | Buy |
2,994,606
+435,694
| +17% | +$44.8M | 0.67% | 21 |
|
|
2023
Q1 | $279M | Buy |
2,558,912
+1,015,212
| +66% | +$111M | 0.63% | 20 |
|
|
2022
Q4 | $176M | Buy |
1,543,700
+537,457
| +53% | +$61.2M | 0.42% | 37 |
|
|
2022
Q3 | $62.3M | Buy |
1,006,243
+888,743
| +756% | +$55M | 0.15% | 155 |
|
|
2022
Q2 | $9.37M | Sell |
117,500
-262,500
| -69% | -$20.9M | 0.02% | 689 |
|
|
2022
Q1 | $40M | Buy |
380,000
+230,000
| +153% | +$24.2M | 0.08% | 274 |
|
|
2021
Q4 | $16.2M | Sell |
150,000
-1,755,000
| -92% | -$189M | 0.03% | 553 |
|
|
2021
Q3 | $209M | Sell |
1,905,000
-345,000
| -15% | -$37.8M | 0.41% | 49 |
|
|
2021
Q2 | $211M | Buy |
2,250,000
+650,000
| +41% | +$60.9M | 0.41% | 45 |
|
|
2021
Q1 | $147M | Sell |
1,600,000
-850,000
| -35% | -$78.2M | 0.3% | 70 |
|
|
2020
Q4 | $179M | Sell |
2,450,000
-1,240,772
| -34% | -$90.8M | 0.39% | 46 |
|
|
2020
Q3 | $287M | Buy |
3,690,772
+434,823
| +13% | +$33.8M | 0.72% | 17 |
|
|
2020
Q2 | $181M | Buy |
+3,255,949
| New | +$181M | 0.46% | 39 |
|
|
2020
Q1 | – | Sell |
-1,000,000
| Closed | -$36.2M | – | 818 |
|
|
2019
Q4 | $36.2M | Sell |
1,000,000
-500,000
| -33% | -$18.1M | 0.09% | 262 |
|
|
2019
Q3 | $40.8M | Buy |
1,500,000
+100,000
| +7% | +$2.72M | 0.1% | 233 |
|
|
2019
Q2 | $33.7M | Buy |
1,400,000
+400,000
| +40% | +$9.62M | 0.08% | 267 |
|
|
2019
Q1 | $26.4M | Buy |
1,000,000
+425,000
| +74% | +$11.2M | 0.07% | 319 |
|
|
2018
Q4 | $11.2M | Buy |
+575,000
| New | +$11.2M | 0.03% | 488 |
|
|
2014
Q2 | – | Sell |
-350,000
| Closed | -$5.29M | – | 766 |
|
|
2014
Q1 | $5.29M | Buy |
+350,000
| New | +$5.29M | 0.01% | 583 |
|